The accidental discovery of the mouse polyoma virus nearly 50 years ago opened up an experimental system unique in opportunities for investigating virus-host interactions leading to the development of tumors. Extensive studies of the virus in tissue culture have provided a detailed understanding of its genetics and molecular biology. Knowledge of the virus as a transforming agent in culture can now be tested in the animal where multiple cell types are targets for tumorigenic conversion and where a variety of host factors, both immunological and nonimmunological, come into play. Studies in the animal using well-characterized wild-type and mutant virus strains have led to some unexpected findings. Some of these run counter to certain widely held beliefs in cancer biology. This minireview focuses on these surprising findings and the challenges they raise.
INTRODUCTION
Polyoma virus emerged in a surprising fashion in the course of experiments aimed at demonstrating a viral agent in mouse leukemia. Newborn mice injected with cell-free extracts of leukemic tissues developed, instead of leukemia, salivary gland carcinomas and a range of other solid tumors (Eddy, 1969; Gross, 1983) . The agent responsible for this action was given the name "polyoma" for its ability to induce multiple tumors. These have now been shown to arise from more than a dozen different cell types (Dawe et al., 1987b) . While many of these tumors remain microscopic, others grow rapidly, such that the total tumor mass in an animal just 3 months of age may comprise 25% or more of its total body weight. Figure 1 illustrates the remarkable ability of this virus to induce tumors in its natural host. Large tumors arising from mammary gland, salivary gland, and thymus are easily seen along with multiple tumors in the skin which arise from hair follicles. In addition to these epithelial tumors, tumors of mesenchymal origin, most commonly renal sarcomas, osteosarcomas, hemangiomas, and subcutaneous fibrosarcomas, are seen (Dawe et al., 1987b) . The virus has also been shown to induce other pathologies including a runting syndrome (Bauer et al., 1995; Bolen et al., 1985) , a myeloproliferative disease (Szomolanyi-Tsuda et al., 1994) , polyarteritis (Dawe et al., 1987a) , as well as effects in enhancing autoimmune disease (Tonietti and Oldstone, 1970) , depending in part on the particular virus strain and host genetic backgrounds.
Following soon on its discovery, the virus was adapted to cell culture and shown to induce neoplastic transformation of cells in vitro. Quantitative assays for virus replication were developed based on plaque formation on mouse cells. Assays for cell transformation utilized rat or hamster fibroblasts which are nonpermissive for virus replication and resistant to the lytic effects of the virus. Figure 2 shows the transformation of established rat embryo fibroblasts by polyoma based on focus formation and growth in soft agar. Our knowledge of the molecular biology of polyoma derives almost entirely from studies of the virus in these cell culture systems (Cole, 1996) .
Studies of oncogenic viruses as agents of cell transformation have led to important discoveries with relevance to human cancer. The ras, myc, fos, abl, and src oncogenes and the p53, erbB2, and Wnt-APC tumor suppressor gene pathways are a few prominent examples of genes and pathways whose origins of discovery are grounded in research on tumor viruses. These in vitro systems nevertheless have obvious limitations as models for tumor induction. The cell culture systems used to identify and characterize viral oncogenes utilize fibroblasts almost exclusively as target cells. Opportunities to extend observations from tissue culture into the animal have not always been available or pursued. Polyoma is one of the few oncogenic viruses amenable to study both in culture and in its natural host. The polyoma-mouse system thus affords opportunities to test the relevance of transforming functions in the context of tumor formation in a variety of tissues and also to explore roles of the host genetic background in determining susceptibility or resistance to tumor development. In the nearly 50 years since its discovery, research on polyoma virus has come full circle-from the mouse to tissue culture and back to the mouse.
ESSENTIAL FEATURES OF THE VIRUS
Three features of the virus contribute at different levels to its ability to induce tumors so broadly and rapidly. VP1, the outer capsid protein, binds to sialic acid as an essential component of cell receptors (Chen and Benjamin, 1997) . Sialic acid in the appropriate linkage is present as the terminal saccharide on many glycoproteins. There is no evidence for a unique receptor species for polyoma (Bauer et al., 1999) . Rather, it is assumed that a heterogeneous class of sialoglycoproteins can serve as primary receptors or attachment proteins for the virus. Such proteins are abundantly and broadly expressed on cell surfaces. The virus is thus able to establish a rapid and widely disseminated infection in the newborn mouse. This can be visualized by "whole mouse section" hybridization as shown in Fig. 3 . Microscopic examination of H & E sections immunostained for VP1 shows that the virus can replicate in more than 40 different cell types (Dawe et al., 1987b) .
The virus has a versatile "multivalent" enhancer region enabling it to be transcribed and to replicate in many different cell types. The viral genome is a small doublestranded circular DNA of 5.3 kb. A stretch of about 450 bp of noncoding DNA contains a replication origin flanked by regulatory sequences that control expression from the early and late viral promoters. This region is rich in binding sites for cellular transcription factors. Perhaps 8 or 10 different factors-some of the "household" variety such as members of the AP-1 family-have been shown to bind in this region. A scan of the viral regulatory sequences reveals as many as 30 possible binding sites for known transcription factors. Some of these putative sites may be used by the virus to replicate in various target cells in vivo. Roles for different enhancer elements in age-specific and tissue-specific virus replication as well as in tumor induction have been demonstrated experimentally Campbell and Villarreal, 1988; Freund et al., 1988a; Rochford et al., 1990a Rochford et al., ,b, 1992 Rochford and Villarreal, 1991; Wirth et al., 1992) .
Three T ("tumor") antigens encoded by the virus interact with multiple cellular factors involved in growth signaling pathways. Thus, while serving essential functions in virus replication, the T antigens also have the potential for altering cell growth controls. Table 1 summarizes some of the known interactions between the polyoma T antigens and cellular proteins. Middle T, the major transforming protein, is an integral membrane protein that binds and activates the tyrosine protein kinase pp60 c-src and other members of the c-src family. Middle T alone can transform some established fibroblasts (Treisman et al., 1981) , and regulated expression allows reversible control over the transformed phenotype (Raptis et al., 1985) . Middle T serves as both an activator and substrate of pp60 c-src (Talmage et al., 1989) . Phosphorylated middle T binds and triggers the action of at least three cellular proteins involved in intracellular signaling and mitogenesis: phospatidylinositol 3-kinase (Auger et al., 1992; Talmage et al., 1989; Whitman et al., 1985) , phospholipase C-␥ (Su et al., 1995) , and Shc (Campbell et al., 1994; Dilworth et al., 1994) . Large T but not middle T is able to override p53-induced arrest Freund, 1997, 1999) . Large T binds and inactivates the retinoblastoma gene product pRb (Freund et al., 1992 (Freund et al., , 1994 as well as the transcriptional coactivators p300/CBP (Cho et al., 2001; Nemethova and Wintersberger, 1999) . Small T has a number of interesting properties most likely linked to its ability to bind and inhibit the protein phosphatase PP2A (Pallas et al., 1990) . The role of the J domain present in all three T antigens is important in mediating certain T antigen functions including interactions with other proteins (Campbell et al., 1995; Glenn and Eckhart, 1995) .
Despite the extensive knowledge of T antigen functions now available, there is reason to believe that some important pieces of the puzzle may still be missing concerning how polyoma replicates and induces tumors so efficiently. This calls for new genetic screens or other approaches designed to uncover possible additional functions of the virus and cellular targets with which the T antigens may interact.
SURPRISES AND CHALLENGES

Viral determinants
Not all "wild-type" virus strains are able to induce tumors in the mouse. Large plaque or "high tumor" strains induce tumors in essentially 100% of animals with an average latency of 3-4 months. Small plaque or "low tumor" strains induce few or frequently no tumors; moreover, tumors which arise do so with a much longer latency (6 months to a year) and are strictly of mesenchymal and never epithelial origin (Dawe et al., 1987b) . Paradoxically, small plaque strains are generally found to have an equal or sometimes higher efficiency of cell transformation in vitro compared to large plaque strains. The operative difference between "high" and "low" tumor strains lies not in their transforming proteins (Freund et al., 1988b) but in a single amino acid substitution in the major capsid protein VP1 (Freund et al., 1991a) . Results from multiple approaches-genetic, biochemical, biological-point to the importance of this substitution in allowing the virus to discriminate between different sialic acid linkages. This ability in turn governs the extent and rapidity of virus spread in the animal (Bauer et al., 1999; Dubensky et al., 1991; Freund et al., 1991a Freund et al., ,b, 1988 . Results of X-ray crystallographic studies have shown that the residues involved form part of the sialic acid binding pocket on the virus surface (Stehle et al., 1994) . Curiously, the high tumor strain is able to bind only single straight chain sialic acids while the low tumor strain binds branched as well as straight chain sialic acids. The fact that small plaque strains, with broader binding specificity, are restricted in their replication in the mouse raises the possibility that these strains recognize and bind to a class of natural inhibitors or pseudoreceptors expressed in the host (Bauer et al., 1999; Stehle et al., 1994) .
These findings raise several challenges focused on the need for a better understanding of the earliest events in viral infection. Given the broad spectrum of host cell types the virus can infect and the presumably heterogeneous class of receptor molecules it utilizes, what pathway of uptake, cell entry, uncoating, and transport to the nucleus does the virus follow, and are these the same in different cell types? What is the nature of the presumed pseudoreceptor that limits small plaque virus strains from replicating in the mouse?
Some T antigen functions are essential for transformation but are not required for tumor induction. This is best illustrated by studies of a middle T mutant unable to bind the Shc adaptor protein. This mutant, blocked in signaling via the ras-raf-MAP kinase pathway, is defective in transforming cells in culture yet induces a broad spectrum of tumors in the mouse (Bronson et al., 1997) . In specific target tissues, for example skin, the mutant induces tumors that are several hundred times larger than those induced by the wild-type virus, while in other tissues such as thymus, tumors induced by the mutant are smaller.
Results with this and other T antigen mutants indicate that differences in growth controls operating in various target cells affect the response to the virus and the likelihood of undergoing neoplastic transformation. The "rules" for transforming fibroblasts in culture are not entirely the same as those for inducing tumors in the intact host. Different transforming pathways initiated by the virus may act in a largely redundant manner to induce tumors in some cell types and in a complementing or synergistic manner in other types. At least one pathway essential for transformation has a negative effect on tumor formation in a particular target cell (Bronson et al., 1997) . Understanding the "hard-wiring" of growth controls in each cell type will be necessary to understand its response to the virus and the specific alterations required for tumorigenic conversion.
Two examples have been found of the converse relationship, i.e., where a mutant virus is able to transform in culture but is defective in inducing tumors. These relate to mutations in large T which block replication but leave the middle and small T functions unaffected (Cho et al., 2001; Li et al., manuscript submitted) . These findings emphasize the importance of virus replication and dissemination as a necessary prelude to tumor induction in the mouse.
The ability of the virus to immortalize cells in culture is not essential to its ability to induce tumors. This is shown by studies of large T mutants that are unable to bind the retinoblastoma tumor suppressor protein pRb. These mutants are replication-defective in culture as a result of being unable to overcome G1 arrest. They are also defective in their ability to immortalize primary cells. Remarkably, they remain fully able to replicate in the newborn mouse and they induce a tumor profile closely resembling that induced by wild-type virus (Freund et al., 1992 (Freund et al., , 1994 .
By what means these mutants overcome growth arrest in the animal is unknown. These observations raise the question of whether there may be still unrecognized tumor suppressor proteins or other cellular factors targeted by the virus as essential steps in replication and tumor induction.
Polyoma appears to have no mechanism for directly inactivating p53. In this regard, polyoma stands apart from its close relative SV40, from its more distant cousins the highly oncogenic human papillomaviruses, and from the oncogenic human adenoviruses. Each of these viruses possesses a mechanism for nullifying p53 (reviewed in Howley et al., 1997) . Evidence for a block in signaling between p19 ARF and p53 in established polyoma transformed rat embryo fibroblasts has been reported recently (Lomax and Fried, 2001) . However, in the context of tumor induction in the mouse, the virus appears to have no effective way of blocking p53 (Dey et al., 2000) .
Genomic instability, frequently linked to p53 loss, is a hallmark of cancers in mice as well as in humans. If polyoma is indeed unable to inactivate p53, how is it able to induce tumors so efficiently? To what extent is polyoma tumor development driven by genomic instability? In contrast to spontaneous cancers in humans which evolve through a multihit process, polyoma tumors may arise in a "single hit" from multiple oncogenic events delivered through its T antigens. The development of polyoma tumors may therefore depend little or not at all on genomic instability. If this is so, the tumors should remain strictly under T antigen control, unlike tumors induced by SV40 large T for example (Ewald et al., 1996) . This prediction can be tested experimentally. On the other hand, polyoma tumors, though generally not wildly aneuploid, do show karyotypic changes (Sandros and Stenman, 1990; unpublished observations) . Are there mechanisms still unknown by which the virus can either block or bypass p53? Is there a novel pathway to genomic instability in polyoma tumors that operates independently of p53 inactivation, and if so, what viral functions and cellular targets are involved? New genetic screens and sensitive cytogenetic approaches may help to answer these questions.
A "tumor host range mutant selection procedure" has been devised as a way to identify new cellular targets of polyoma T antigens. Polyoma large T mutants that are unable to bind pRb are in fact host range mutants, i.e., they are able to grow in culture only in cells with a nonfunctional pRb pathway (Freund et al., 1994) . This and other observations suggest that screening for host range mutants that are able to grow in tumor cells but not in normal cells could provide a way to uncover new virushost protein interactions of importance to virus replication and tumorigenesis. Such a procedure has recently been applied to polyoma. The procedure utilizes spontaneous or nonpolyoma tumor-derived cells as permissive hosts and primary baby mouse kidney cells as the nonpermissive hosts (Li et al., manuscript submitted) . Studies of such mutants coupled with yeast two-hybrid screens have led to the identification of new cellular targets of the large T protein. These interactions are important in virus replication. The normal functions of these cellular targets are of interest in terms of their possible roles in regulating cell growth.
Host determinants
Not every strain of mouse is susceptible to tumor induction by polyoma virus. More than 40 inbred strains and some F1 hybrids have been tested. Responses were found to vary from high susceptibility in which 100% of animals come down with multiple tumors within a few months to complete resistance in which no tumors develop even after more than a year. Intermediate phenotypes were also seen in which tumors develop at a reduced frequency, or affecting some target tissues but not others, or in which particular tumors have a high propensity to metastasize (unpublished observations).
Determinants of general resistance. The most common form of resistance to polyoma tumors is based on effective antitumor immunity. This immunological form of resistance was first recognized in C57BL mice. These normally resistant mice become susceptible following neonatal thymectomy, irradiation, or treatment with "antilymphocyte serum" (Allison and Law, 1968; Allison et al., 1974; Law et al., 1967) . Resistance to tumor development is not necessarily coupled with resistance to the virus per se as shown by studies with the C57BR mouse. These mice are susceptible as newborns to the virus but develop no tumors. This is due to a CTL response mediated by CD8 ϩ V␤6 ϩ T cells which effectively eliminate polyoma tumors but do not suppress the early acute phase of virus replication in the newborn animal (Lukacher et al., 1995) . The response is H-2D k -restricted and specific for an immunodominant peptide derived from the middle T protein (Lukacher and Wilson, 1998) . As expected, C57BR mice become susceptible following irradiation (Lukacher et al., 1995) .
A distinctly different form of resistance, seen so far in just a few strains, is directed to the virus and appears to have a nonimmunological basis. Mice of these strains develop few or no tumors even after irradiation . This "radiation-resistant" form of resistance is manifested early in the infectious process, i.e., in blocking virus replication and spread. These mice also survive infection by a highly virulent strain of polyoma that causes early death from widespread lytic infection in most other strains of mice (Bauer et al., 1995) . These observations are consistent with the view that this form of resistance is directed to the virus as opposed to the tumors. Interestingly, cells in culture derived from these resistant mice are susceptible to infection by the virus.
These findings raise several interesting challenges. One concerns the role of neonatal versus adult immunity in controlling virus spread and tumor induction (Moser et al., 2001) . Understanding the mechanism of nonimmunological host resistance that effectively shuts down virus replication in vivo is another.
Determinants of susceptibility. One form is dependent on endogenous superantigen (Lukacher et al., 1995) and the other is superantigen-independent (Velupillai et al., 1999) . The classical inbred mouse strains known to be highly susceptible to polyoma owe their susceptibility to their MHC type (H-2 k ) and to an endogenous mouse mammary tumor provirus, Mtv-7. The Mtv-7 provirus encodes a superantigen which effectively deletes V␤6 ϩ T cells, thus rendering these mice unable to mount an effective CTL response to polyoma tumors. Interestingly, while T cell deletion by an endogenous Mtv superantigen constitutes a susceptibility determinant to polyoma, the same mechanism can function as a determinant of resistance to the horizontal transmission of a homologous mouse mammary tumor virus (Golovkina et al., 1992) .
A different basis of susceptibility has been identified in certain strains of "wild-derived" inbred mice. These strains carry no detectable endogenous mouse mammary tumor proviruses yet are as fully susceptible to tumor induction by polyoma as the classical inbreds with superantigen-mediated susceptibility (Velupillai et al., 1999) . These mice possess the precursors required to generate polyoma-specific CTLs but develop a "type 2" T cell immunity in response to the virus and fail to sustain a CTL response (Velupillai et al., manuscript in preparation) .
Superantigen-dependent and -independent forms of susceptibility are similar in their inability to mount or sustain effective antitumor immune responses. Both forms are transmitted in a dominant or codominant fashion in crosses with MHC-identical immunologically resistant mice, implying that both operate by mechanisms that actively interfere with generating effective tumor immunity. The genetic basis of superantigen-independent susceptibility remains unknown but appears to be due to one or two dominantly acting genes (Velupilai et al., 1999) . Some host factors affect tumor incidence or tumor behavior in a tissue-specific way. These phenotypes include specific resistance to the development of mammary tumors in one strain and propensity for bone tumors to metastasize in another (unpublished observations). The genetic and physiological bases for these host responses are unknown.
The mouse has long been a subject of basic cancer research. Mouse genetics is now aided by rapidly improving methods for mapping, identifying, and manipulating genes. These genetic methods coupled with physiological studies will hopefully lead to an understanding of the molecular mechanisms underlying these interesting host phenotypes.
